KITLG and Alzheimer disease: This system-level understanding of how the bioactive compounds in SCF interact with the key targets and pathways involved in AD pathology can offer crucial insights to guide the exploration of SCF as a novel, multifaceted therapeutic approach for this devastating neurodegenerative disorder.